Manufacturing Compliance Woes Wilt Glenmark

 
• By Anju Ghangurde

An FDA audit flagged up compliance deviations at Glenmark’s manufacturing facility in Baddi, piling up pressure on the firm in an already challenging business environment that saw it report subdued Q2 earnings.

Pharmaceutical production
GLENMARK's BADDI UNIT HAS FAILED TO CLEAR AN FDA AUDIT • Source: Shutterstock

More from Business

More from Scrip